Polaris Management Co. VII, L.L.C.
Insider CIK 1678203 · SYRS 10% owner · SQZ 10% owner · MTCR 10% owner · CAMP 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CAMP Camp4 Therapeutics Corp | P Buy | 2025-09-11 | 2025-09-11 | 1,221,721 | $1.53 | $1.87M | 2,825,500 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | P Buy | 2025-09-11 | 2025-09-11 | 85,468 | $1.53 | $130.8K | 197,661 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | C Conversion deriv | 2024-10-15 | 2024-10-15 | 980,829 | — | $0 | 0 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | C Conversion deriv | 2024-10-15 | 2024-10-15 | 14,020,475 | — | $0 | 0 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | C Conversion deriv | 2024-10-15 | 2024-10-15 | 3,967,234 | — | $0 | 0 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | C Conversion deriv | 2024-10-15 | 2024-10-15 | 277,536 | — | $0 | 0 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | C Conversion deriv | 2024-10-15 | 2024-10-22 | 3,967,234 | — | $0 | 0 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | C Conversion deriv | 2024-10-15 | 2024-10-22 | 14,020,475 | — | $0 | 0 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | C Conversion deriv | 2024-10-15 | 2024-10-22 | 277,536 | — | $0 | 0 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | C Conversion deriv | 2024-10-15 | 2024-10-22 | 980,829 | — | $0 | 0 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | C Conversion | 2024-10-15 | 2024-10-15 | 353,718 | — | $0 | 1,603,779 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | P Buy | 2024-10-15 | 2024-10-15 | 909,090 | $11.00 | $10.00M | 909,090 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | C Conversion | 2024-10-15 | 2024-10-15 | 24,745 | — | $0 | 112,193 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | C Conversion | 2024-10-15 | 2024-10-15 | 1,250,061 | — | $0 | 1,250,061 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | C Conversion | 2024-10-15 | 2024-10-15 | 87,448 | — | $0 | 87,448 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | C Conversion | 2024-10-15 | 2024-10-22 | 24,745 | — | $0 | 112,193 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | C Conversion | 2024-10-15 | 2024-10-22 | 353,718 | — | $0 | 1,603,779 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | C Conversion | 2024-10-15 | 2024-10-22 | 87,448 | — | $0 | 87,448 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | C Conversion | 2024-10-15 | 2024-10-22 | 1,250,061 | — | $0 | 1,250,061 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | P Buy | 2024-10-15 | 2024-10-22 | 909,090 | $11.00 | $10.00M | 909,090 | SEC↗ |
| SQZ SQZ Biotechnologies Co | C Conversion deriv | 2020-11-03 | 2020-11-03 | 28,863 | — | $0 | 0 | SEC↗ |
| SQZ SQZ Biotechnologies Co | C Conversion deriv | 2020-11-03 | 2020-11-03 | 412,608 | — | $0 | 0 | SEC↗ |
| SQZ SQZ Biotechnologies Co | C Conversion deriv | 2020-11-03 | 2020-11-03 | 56,462 | — | $0 | 0 | SEC↗ |
| SQZ SQZ Biotechnologies Co | C Conversion deriv | 2020-11-03 | 2020-11-03 | 807,096 | — | $0 | 0 | SEC↗ |
| SQZ SQZ Biotechnologies Co | C Conversion deriv | 2020-11-03 | 2020-11-03 | 44,120 | — | $0 | 0 | SEC↗ |
| SQZ SQZ Biotechnologies Co | C Conversion deriv | 2020-11-03 | 2020-11-03 | 630,672 | — | $0 | 0 | SEC↗ |
| SQZ SQZ Biotechnologies Co | C Conversion deriv | 2020-11-03 | 2020-11-03 | 348,725 | — | $0 | 0 | SEC↗ |
| SQZ SQZ Biotechnologies Co | C Conversion deriv | 2020-11-03 | 2020-11-03 | 24,397 | — | $0 | 0 | SEC↗ |
| SQZ SQZ Biotechnologies Co | C Conversion | 2020-11-03 | 2020-11-03 | 161,994 | — | $0 | 161,994 | SEC↗ |
| SQZ SQZ Biotechnologies Co | C Conversion | 2020-11-03 | 2020-11-03 | 2,315,652 | — | $0 | 2,315,652 | SEC↗ |
| SQZ SQZ Biotechnologies Co | P Buy | 2020-11-03 | 2020-11-03 | 233,654 | $16.00 | $3.74M | 2,549,306 | SEC↗ |
| SQZ SQZ Biotechnologies Co | P Buy | 2020-11-03 | 2020-11-03 | 16,346 | $16.00 | $261.5K | 178,340 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion deriv | 2020-09-18 | 2020-09-22 | 451,666 | — | $0 | 0 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion deriv | 2020-09-18 | 2020-09-22 | 216,106 | — | $0 | 0 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion deriv | 2020-09-18 | 2020-09-22 | 20,585 | — | $0 | 0 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion deriv | 2020-09-18 | 2020-09-22 | 15,118 | — | $0 | 0 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion deriv | 2020-09-18 | 2020-09-22 | 128,201 | — | $0 | 0 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion deriv | 2020-09-18 | 2020-09-22 | 1,832,582 | — | $0 | 0 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion | 2020-09-18 | 2020-09-22 | 128,201 | — | $0 | 143,239 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion | 2020-09-18 | 2020-09-22 | 216,106 | — | $0 | 2,715,316 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion | 2020-09-18 | 2020-09-22 | 20,585 | — | $0 | 163,824 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion | 2020-09-18 | 2020-09-22 | 451,666 | — | $0 | 2,499,210 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion | 2020-09-18 | 2020-09-22 | 15,118 | — | $0 | 178,942 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion | 2020-09-18 | 2020-09-22 | 1,832,582 | — | $0 | 2,047,544 | SEC↗ |
| MTCR Metacrine, Inc. | P Buy | 2020-09-18 | 2020-09-22 | 15,038 | $13.00 | $195.5K | 15,038 | SEC↗ |
| MTCR Metacrine, Inc. | P Buy | 2020-09-18 | 2020-09-22 | 214,962 | $13.00 | $2.79M | 214,962 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion deriv | 2016-07-06 | 2016-07-07 | 4,366,825 | — | $0 | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion deriv | 2016-07-06 | 2016-07-07 | 83,129 | — | $0 | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion | 2016-07-06 | 2016-07-07 | 22,167 | — | $0 | 22,167 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | P Buy | 2016-07-06 | 2016-07-07 | 373,847 | $12.50 | $4.67M | 1,538,333 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | P Buy | 2016-07-06 | 2016-07-07 | 26,153 | $12.50 | $326.9K | 48,320 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion | 2016-07-06 | 2016-07-07 | 1,164,486 | — | $0 | 1,164,486 | SEC↗ |